House Bill 5668
116th Congress(2019-2020)
MODERN Labeling Act of 2020
Active
Passed House on Nov 17, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5668
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on November 17, 2020
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5805-5806)
Summary
Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020
This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.
November 18, 2020
November 17, 2020
November 16, 2020
January 24, 2020
11/18/2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
11/17/2020
Motion to reconsider laid on the table Agreed to without objection.
11/17/2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5805-5806)
11/17/2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5805-5806)
11/17/2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 5668.
11/17/2020
Considered under suspension of the rules. (consideration: CR H5805-5807)
11/17/2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
11/16/2020
Placed on the Union Calendar, Calendar No. 471.
11/16/2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.
07/15/2020
Ordered to be Reported (Amended) by Voice Vote.
07/15/2020
Committee Consideration and Mark-up Session Held.
03/11/2020
Subcommittee Consideration and Mark-up Session Held.
03/11/2020
Ordered to be Reported (Amended) by Voice Vote.
01/25/2020
Referred to the Subcommittee on Health.
01/24/2020
Referred to the House Committee on Energy and Commerce.
01/24/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:44:19 PM